SCHEMBL7290141

SCHEMBL7290141

CCCOc1cc(OC)ccc1C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.51
POLB P06746 2/20 0.51
MTNR1A P48039 2/20 0.50
MTNR1B P49286 2/20 0.50
HDAC3 O15379 1/20 0.48
HDAC1 Q13547 1/20 0.48
HDAC2 Q92769 1/20 0.48
PPARG P37231 1/20 0.48
PPARA Q07869 1/20 0.48
AKR1C3 P42330 4/20 0.48
AKR1C2 P52895 4/20 0.48
SMN1; SMN2 Q16637 1/20 0.47
NPC1 O15118 1/20 0.47
ADRB1 P08588 1/20 0.47
ADRB3 P13945 1/20 0.47
LMNA P02545 1/20 0.47
KMT2A Q03164 1/20 0.46
ALDH1A1 P00352 1/20 0.46
PLA2G2A P14555 1/20 0.46
HTR2A P28223 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4304889 0.94 PPARG (0.55) KDM4EPOLBHDAC3HDAC1HDAC2
SCHEMBL2454085 0.91 PPARG (0.56) HDAC3HDAC1HDAC2PPARGPPARA
SCHEMBL28529318 0.90 KMT2A (0.57) KDM4EPOLBADRB1ADRB3LMNA
SCHEMBL8902012 0.89 THRA (0.54) KDM4EHDAC3HDAC1HDAC2PPARG
SCHEMBL7962117 0.87 KDM4E (0.58) KDM4ESMN1; SMN2ADRB1ADRB3LMNA
SCHEMBL11769955 0.87 SMN1; SMN2 (0.55) KDM4EPOLBMTNR1AMTNR1BAKR1C3
SCHEMBL1546492 0.87 KDM4E (0.57) KDM4EPOLBAKR1C3AKR1C2SMN1; SMN2
SCHEMBL29653680 0.86 KMT2A (0.47) KDM4EPOLBSMN1; SMN2NPC1ADRB1
SCHEMBL10848345 0.86 KDM4E (0.47) KDM4EPOLBHDAC3HDAC1HDAC2
SCHEMBL6043905 0.86 KDM4E (0.47) KDM4EPOLBHDAC3HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240019746-A1 ULTRA-HIGH-POLARITY CHIRAL LIQUID CRYSTAL MATERIAL, LIQUID CRYSTAL LASER AND PREPARATION METHOD THEREFOR SOUTH CHINA UNIVERSITY OF TECHNOLOGY (CN) 2024-01-18 US disclosed
US-20240019746-A1 ULTRA-HIGH-POLARITY CHIRAL LIQUID CRYSTAL MATERIAL, LIQUID CRYSTAL LASER AND PREPARATION METHOD THEREFOR SOUTH CHINA UNIVERSITY OF TECHNOLOGY (CN) 2024-01-18 US disclosed
US-20240019746-A1 ULTRA-HIGH-POLARITY CHIRAL LIQUID CRYSTAL MATERIAL, LIQUID CRYSTAL LASER AND PREPARATION METHOD THEREFOR SOUTH CHINA UNIVERSITY OF TECHNOLOGY (CN) 2024-01-18 US disclosed
CN-112322306-B Ultrahigh-polarity chiral liquid crystal material, liquid crystal laser and preparation method thereof 华南理工大学 2022-05-24 CN disclosed
WO-2022089501-A1 ULTRA-HIGH-POLARITY CHIRAL LIQUID CRYSTAL MATERIAL, LIQUID CRYSTAL LASER AND PREPARATION METHOD THEREFOR 华南理工大学 2022-05-05 WO disclosed
CN-112375168-B Side chain rod-shaped polar liquid crystal polymer, preparation method thereof and application thereof in nonlinear optical field 华南理工大学 2022-03-29 CN disclosed
CN-112375168-A Side chain rod-shaped polar liquid crystal polymer, preparation method thereof and application thereof in nonlinear optical field 华南理工大学 2021-02-19 CN disclosed
CN-112342032-A Rod-like polar liquid crystal molecule, preparation method thereof and rod-like polar nematic liquid crystal 华南理工大学 2021-02-09 CN disclosed
CN-112322306-A Ultrahigh-polarity chiral liquid crystal material, liquid crystal laser and preparation method thereof 华南理工大学 2021-02-05 CN disclosed
WO-2015184383-A1 ARYL-SUBSTITUTED IMIDAZOLES AND METHODS OF MAKING AND USING SAME ST. JUDE CHILDREN'S RESEARCH HOSPITAL (US) 2015-12-03 WO disclosed
US-7622480-B2 Selective H1 histamine receptor antagonists; bronchial asthma, allergic rhinitis, conjunctivitis, dermatitis, urticaria and other allergic diseases; e.g. 3-(4-[1-(2-methoxyethyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]piperidin-1-ylmethyl)benzoic acid LABORATORIOS ALMIRALL S.A. (ES) 2009-11-24 US disclosed
US-7622480-B2 Selective H1 histamine receptor antagonists; bronchial asthma, allergic rhinitis, conjunctivitis, dermatitis, urticaria and other allergic diseases; e.g. 3-(4-[1-(2-methoxyethyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]piperidin-1-ylmethyl)benzoic acid LABORATORIOS ALMIRALL S.A. (ES) 2009-11-24 US disclosed
US-5597841-A 2-saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof STERLING WINTHROP, INC. (US) 1997-01-28 US disclosed
EP-0594257-B1 2-Saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof STERLING WINTHROP INC (US) 1996-07-10 EP disclosed
US-5512589-A TREATING DEGENERATIVE DISEASES STERLING WINTHROP INC. (US) 1996-04-30 US disclosed
EP-0594257-A1 2-Saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof STERLING WINTHROP INC. (US) 1994-04-27 EP disclosed
US-5306818-A Treating degenerative diseases such as emphysema, rheumatoid arthritis and pancreatitis STERLING WINTHROP INC. (US) 1994-04-26 US disclosed